Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Combining α-blockers with 5α-reductase inhibitors improves symptoms and outcomes for severe benign prostatic hyperplasia.

PRFM may help treat hair loss, especially in mild cases.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Adding stromal vascular fraction to platelet-rich plasma injections did not significantly improve hair growth in androgenetic alopecia treatment.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Finasteride helps induce ovulation in nonresponder PCOS women.

5α-reduced neurosteroids may help regulate glial cell differentiation.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

HGF/SF injections can stimulate hair growth and increase hair follicle size in mice.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.